Related Experiment Video
Updated: Jan 9, 2026

Validation of a Mouse Model to Disrupt LINC Complexes in a Cell-specific Manner
Published on: December 10, 2015
The research progress of LACC1.
Feng Li1,2, Xinyi Cui1,2, Qingli Yang1,2
1Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Laccase Domain-Containing 1 (LACC1) is a key immune-metabolic hub in macrophages, regulating autophagy and inflammation. It offers potential therapeutic targets for immune and metabolic diseases.
Area of Science:
- Immunology
- Metabolism
- Molecular Biology
Background:
- Laccase Domain-Containing 1 (LACC1) is highly expressed in myeloid macrophages.
- LACC1 integrates lipid, polyamine, and purine metabolism, coordinating immune responses.
Purpose of the Study:
- To comprehensively discuss the molecular structure, enzymatic functions, and signaling pathways of LACC1.
- To summarize pathogenic mechanisms and research advancements of LACC1 in various diseases.
Main Methods:
- Literature review and pathway analysis.
- Comprehensive discussion of LACC1's role in cellular processes and disease.
Main Results:
- The M-CSF/AKT/mTOR/LACC1 pathway regulates autophagy.
- Multiple signaling pathways (e.g., PPARα, miR-211-5p, AMPK, NF-kB, MAPK, ROS, JAK-STAT, CCL5) are involved in LACC1-mediated inflammation.
- LACC1 is implicated in immune diseases, metabolic disorders, infectious diseases, and neurological conditions.
Conclusions:
- LACC1 acts as a pivotal immune-metabolic hub.
- LACC1 provides novel insights and potential therapeutic targets for related diseases.
More Related Videos
11:04RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
Published on: May 19, 2019
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Related Concept Videos
Mechanism of Lamellipodia Formation
Non-LTR Retrotransposons